Stockreport

Kyn Therapeutics Appoints Douglas Carlson as Chief Financial Officer

Collegium Pharmaceutical, Inc.  (COLL) 
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.collegiumpharma.com
PDF BOSTON--(BUSINESS WIRE)-- Kyn Therapeutics, a clinical-stage biotechnology company developing new immunometabolic therapies for treating cancer, today [Read more]